Clinical Trial

Investigating the Effects of a Haskap Berry Supplement on Cognitive Health

Study acronym: HACVAC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 13, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to investigate the postprandial (2h) and longer term (4 week) effects of a haskap berry supplement on cognitive, vascular, and metabolic function in healthy ageing adults aged 50+.
Trial Details
NCT Number NCT07119788
Lead Sponsor University of Reading
Collaborators: Haskapa Ltd
Conditions Cognition
Enrollment 90 participants
Start Date 2025-06-19
Primary Completion 2026-02 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-08-13